Publications by authors named "Tariq Al-Araimi"
Article Synopsis
- This study examined the prevalence of gastrointestinal (GI) symptoms in patients with lupus and identified factors linked to increased mortality.
- Out of 1160 systemic lupus erythematosus (SLE) patients, 91 displayed GI manifestations, with prevalence rates of 8.53% in kids and 7.75% in adults, showing no significant difference between the groups.
- Key findings highlighted that conditions like ischemic colitis were correlated with longer disease duration and specific autoantibodies, and patients with GI involvement had a higher mortality rate due to complications like sepsis and organ damage.
Aim: This study is a longitudinal multicenter study which aims to find the prevalence, the demographic data, survival and mortality rates of patients with systemic lupus erythematosus (SLE) in Oman.
Method: All Omani patients, pediatrics and adults diagnosed with SLE, who fulfill either the 1997 American College of Rheumatology or Systemic Lupus International Collaborating Clinics classifications criteria for SLE were included from January 2006 till February 2020.
Results: In total 1160 patients were included in this cohort.
Objectives: Vedolizumab (VDZ) blocks α4β7 integrin and is licenced for the treatment of IBD. It has been associated with mild SpA-related features, including sacroiliitis and synovitis. Herein we report a series of cases demonstrating the emergence of severe SpA-associated enthesitis/osteitis following successful IBD therapy with VDZ.
View Article and Find Full Text PDF